HTAi Annual Meeting, June 1 -5, Vancouver, Canada

24-05-18DRG Admin

Join our team at Booth 1 at HTAi Annual Meeting to explore our latest insights and discuss your current HTA and market access challenges.

DRG Abacus and Context Matters have joined forces, forming the DRG Solutions for Global Access, to deliver world-class data, insights, and expertise to support evidence-based HTA submissions and global market access.

Our HTA experts will be delivering a range of presentations on the critical trends impacting the industry, including regulatory, HTA decision making, and the use of real world evidence in technology appraisals.

 

Symposium

Local, national, or global – At what level should HTA be conducted?

 

Moderator

Ruth Howells, Practice Lead, DRG Abacus

 

Panel

Prashanth Kandaswamy, Value Dossier and Market Access Expert, Grünenthal GmbH

Chris McCabe, CEO and Executive Director, Institute of Health Economics

Ed Wilson, Senior Research Associate in Health Economics, Cambridge Centre for Health Services Research, University of Cambridge

Jenny Lee, HTA Senior Consultant, DRG Abacus

Judith Rubinstein, Senior Director, Context Matters

 ------------ 

 Pre-Conference Workshop

Expert elicitation for health technology assessment: The what, why and how?

Saturday, June 2, 8:30 AM – 12:00 PM

 

Presenters

Ed Wilson, Senior Research Associate in Health Economics, Cambridge Centre for Health Services Research, University of Cambridge

Jenny Lee, HTA Senior Consultant, DRG Abacus

Jon Tosh, Consultant Health Economist, DRG Abacus

 ------------ 

 Panel

Incorporating real-world evidence (RWE) into regulatory and health technology assessment (HTA) decision-making

Sunday, June 3, 10:45 AM – 12:00 PM

 

Moderator

Yin Ho, Founder & CEO, Context Matters

 

Presenters

Gergana Zlateva, VP, Payer Insights and Access, Pfizer

Gregory Daniel, Deputy Director, Duke-Margolis Center for Health Policy

Newell McElwee, Vice President, Health Economics and Outcomes Research, Boehringer-Ingelheim

 ------------ 

 Oral Presentation

Use of real-world evidence in HTA decision-making from seven agencies

Sunday, June 3, 2:00 PM – 4:00 PM

Ashley Jaksa, Consultant, Context Matters

------------ 

Poster Presentations

How IO drugs changed the landscape of non-small-cell lung cancer

Sunday, June 3, 12:45 PM – 1:15 PM

Judith Rubinstein, Senior Director, Context Matters

 

How does a patient access scheme affect SMC decision-making?

Monday, June 4, 10:45 AM – 11:15 AM

Judith Rubinstein, Senior Director, Context Matters

We are part of Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd.

DRG offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 1,000 employees across 17 offices in North America, Europe and Asia.

Our Company
© DRG Abacus 2020